GENSCRIPT BIO (01548) Stock Price, News, Quotes-Moomoo

HK Stock MarketDetailed Quotes

01548 GENSCRIPT BIO

Watchlist

11.880
+0.180+1.54%

Trading Oct 17 13:35 CST

25.29BMarket Cap-18305P/E (TTM)

Intraday

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Genscript Biotech Unit Logs $286 Million in Sales From Carvykti in July-September
MT NewswiresOct 16 00:53 ET
Genscript Bio announced that the third-quarter net trade sales of CARVYKTI was approximately 0.286 billion US dollars.
Genscript Bio (01548) announced that Legend Biotech Co., Ltd. (Legend Biotech, a non-wholly-owned subsidiary of the company, whose shares are listed on the Nasdaq Global Select Market in the United States in the form of American depositary shares) submitted a 6-K form to the United States Securities and Exchange Commission (SEC) on October 15, 2024 (New York time, after the Hong Kong trading session on October 15, 2024).
Oct 15 20:57 ET
Trending Industry Today: TIGERMED Leads Losses In Biotechnology Stocks
Moomoo NewsOct 13 23:20 ET
Trending Industry Today: TIGERMED Leads Losses In CRO Stocks
Moomoo NewsOct 13 23:00 ET
Genscript Biotech Corporation's (HKG:1548) Stock Price Dropped 13% Last Week; Private Companies Would Not Be Happy
Simply Wall StOct 13 20:55 ET
Trending Industry Today: JOINN Leads Gains In CRO Stocks
Moomoo NewsOct 7 01:20 ET

Comments

Moomoo AI

Mar 13 17:52

Genscript Biotech's high P/S ratio is due to its promising revenue outlook. The company's strong performance and bright future are likely to keep supporting the share price unless conditions change.

Genscript Biotech Corporation's (HKG:1548) P/S Is Still On The Mark Following 29% Share Price Bounce

Moomoo AI

Mar 8 07:06

GenScript's leadership values Dr. Liu's expertise in genome editing, chemistry, and synthetic biology for its potential to offer key insights. His addition to the SAB is anticipated to boost GenScript's platform and hasten transformative breakthroughs for patients.

Press Release: Dr. David Liu Joins GenScript's Scientific Advisory Board to Guide Company's Innovation Strategy

Moomoo AI

Mar 6 09:06

Dr. June joining GenScript's SAB could provide invaluable insights for their initiatives, especially in cell and gene therapy. His expertise may accelerate the development of novel therapies.

Press Release: Immunotherapy Pioneer Carl H. June, MD, Joins GenScript's Scientific Advisory Board to Guide Company's Innovation Strategy in Advancing Cell and Gene Therapy Breakthroughs

Spinee

Jan 17 02:21

HSI Plunge Once Deepens to 620 Pts; Pharmas In Sell-off

$Hang Seng Index (800000.HK)$ plunge deepened unceasingly after midday. It once stumbled 620 pts or 3.9% to bottom at 15,245, hitting an over-14-month low; last at 15,320, down 545 pts or 3.4%, with a total turnover of $88.5 billion.
Pharmaceuticals were sold off. $REMEGEN (09995.HK)$ once collapsed 27.5% to $22.8; last at $24.9, down 21%.
$CLOVER BIO-B (02197.HK)$ nosedived 9.6% to $0.47, hitting record low. $VIVA BIOTECH (01873.HK)$ ...

Moomoo AI

Jan 9 00:19

Despite Genscript Biotech's promising revenue outlook, its P/S ratio isn't higher than industry peers due to potential volatility in revenue forecasts. Investors should note the company's 2 warning signs.

Genscript Biotech Corporation's (HKG:1548) Shares Not Telling The Full Story

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data

01548 GENSCRIPT BIO

Trade Overview

Capital Trend

News

Comments

Analysis

Analyst Rating

Price Target